Efficacy of ferric carboxymaltose or darbepoetin alfa for chemotherapy-induced anemia in patients with esophagogastric or pancreaticobiliary cancer: a retrospective comparative study.
Minkwan ChoEunkyung ParkYong-Pyo LeeHongsik KimHee Sue ParkHee Kyung KimYaewon YangJihyun KwonKi Hyeong LeeHye Sook HanPublished in: Therapeutic advances in medical oncology (2024)
Both FCM and DA are effective, and FCM showed a higher Hb response than DA for CIA treatment in patients with esophagogastric or pancreaticobiliary cancer. Therefore, further randomized controlled trials should determine the optimal treatment for CIA in patients with these cancers undergoing myelosuppressive chemotherapy.